1. Jingshu Keli and its Components Notoginsenoside R1 and Ginsenoside Rb1 Alleviate the Symptoms of Cervical Myelopathy through Kir3.1 Mediated Mechanisms
   Renjie Yan et al, 2019, CNS & Neurological Disorders - Drug Targets CrossRef
2. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson’s Disease Mice, Possibly via Impaired Glymphatic Clearance
   Huili Cui et al, 2021, Journal of Molecular Neuroscience CrossRef
3. Research progress in use of traditional Chinese medicine for treatment of spinal cord injury
   Yubao Lu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
4. Ginsenoside Rb1 attenuates microglia activation to improve spinal cord injury via microRNA‐130b‐5p/TLR4/NF‐κB axis
   Dan Wang et al, 2021, Journal of Cellular Physiology CrossRef
5. Ginsenoside Rb1 Alleviates Oxidative Low-Density Lipoprotein–Induced Vascular Endothelium Senescence via the SIRT1/Beclin-1/Autophagy Axis
   Guangyao Shi et al, 2020, Journal of Cardiovascular Pharmacology CrossRef
6. Ginsenoside Rg3 Improves Recovery from Spinal Cord Injury in Rats via Suppression of Neuronal Apoptosis, Pro-Inflammatory Mediators, and Microglial Activation
   Dong-Kyu Kim et al, 2017, Molecules CrossRef
7. Antinociceptive effects of Ginsenoside Rb1 in a rat model of cancer‑induced bone pain
   Fu‑Dong Yao et al, 2019, Experimental and Therapeutic Medicine CrossRef
8. The Role of Saponins in the Treatment of Neuropathic Pain
   Bei Tan et al, 2022, Molecules CrossRef
9. Total saponin extract, ginsenoside Rb1, and compound K alleviate peripheral and central neuropathic pain through estrogen receptors on rats
   Jee Youn Lee et al, 2021, Phytotherapy Research CrossRef
10. The Water Transport System in Astrocytes–Aquaporins
    Zuoyi Zhou et al, 2022, Cells CrossRef
11. Mechanisms of ginsenosides exert neuroprotective effects on spinal cord injury: A promising traditional Chinese medicine
    Le Qi et al, 2022, Frontiers in Neuroscience CrossRef
12. Pretreatment with AQP4 and NKCC1 Inhibitors Concurrently Attenuated Spinal Cord Edema and Tissue Damage after Spinal Cord Injury in Rats
    Xiaodong Yan et al, 2018, Frontiers in Physiology CrossRef
13. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71
    Naixin Kang et al, 2021, Journal of Ethnopharmacology CrossRef
14. Involvement of serotonergic, noradrenergic and dopaminergic systems in the antidepressant-like effect of ginsenoside Rb1, a major active ingredient of Panax ginseng C.A. Meyer
    Guo-Li Wang et al, 2017, Journal of Ethnopharmacology CrossRef
15. Progress of Ginsenoside Rb1 in neurological disorders
    Gongxia Ling et al, 2024, Frontiers in Pharmacology CrossRef
16. Ginsenoside Rb1 protects against spinal cord ischemia-reperfusion injury in rats by downregulating the Bax/Bcl-2 ratio and caspase-3 and p-Ask-1 levels
    Dongxu Zhao et al, 2018, Experimental and Molecular Pathology CrossRef
17. Recent progress (2015–2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb1, a main active ingredient in Panax ginseng Meyer
    Zuan Lin et al, 2022, Journal of Ginseng Research CrossRef
18. Aquaporin 4 regulation by ginsenoside Rb1 intervenes with oxygen-glucose deprivation/reoxygenation-induced astrocyte injury
    Ya-Nan Li et al, 2019, Medicine CrossRef
19. The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury
    Jacek M. Kwiecien et al, 2020, Current Neuropharmacology CrossRef
20. Inhibition of Autophagy is Involved in the Protective Effects of Ginsenoside Rb1 on Spinal Cord Injury
    Peng Wang et al, 2018, Cellular and Molecular Neurobiology CrossRef